These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 23060049)

  • 1. Factors influencing the number of pelvic and para-aortic lymph nodes removed in surgical treatment of endometrial and ovarian cancer.
    Hareyama H; Ito K; Watanabe S; Hakoyama M; Uchida A; Oku K; Watanabe Y; Hayakashi Y; Hirayama E; Okuyama K
    Int J Gynecol Cancer; 2012 Nov; 22(9):1577-84. PubMed ID: 23060049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
    Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
    Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node counts in endometrial cancer: expectations versus reality.
    Euscher ED; Bassett R; Malpica A
    Am J Surg Pathol; 2011 Jun; 35(6):913-8. PubMed ID: 21566518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we omit para-aorta lymph node dissection in endometrial cancer?
    Tanaka H; Sato H; Miura H; Sato N; Fujimoto T; Konishi Y; Takahashi O; Tanaka T
    Jpn J Clin Oncol; 2006 Sep; 36(9):578-81. PubMed ID: 16870694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
    Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
    Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer.
    Fotopoulou C; El-Balat A; du Bois A; Sehouli J; Harter P; Muallem MZ; Krätschell RW; Traut A; Heitz F
    Arch Gynecol Obstet; 2015 Dec; 292(6):1321-7. PubMed ID: 25990476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging.
    Menderes G; Azodi M; Schwartz P; Silasi DA
    Int J Gynecol Cancer; 2015 Jan; 25(1):160-5. PubMed ID: 25386859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Pattern of Spread of Lymph Node Metastasis in Patients With Low-grade Serous Ovarian Cancer.
    Wafa M; Braicu EI; Muallem MZ; Richter R; Taube E; Sehouli J; Grabowski JP
    Anticancer Res; 2019 Oct; 39(10):5617-5621. PubMed ID: 31570458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should pelvic and para-aortic lymphadenectomy be different depending on histological subtype in epithelial ovarian cancer?
    Roger N; Zafrani Y; Uzan C; Gouy S; Rey A; Pautier P; Lhommé C; Duvillard P; Castaigne D; Morice P
    Ann Surg Oncol; 2008 Jan; 15(1):333-8. PubMed ID: 17943386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer.
    Mariani A; Webb MJ; Keeney GL; Podratz KC
    Gynecol Oncol; 2001 Apr; 81(1):100-4. PubMed ID: 11277658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):435-40. PubMed ID: 21781585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.
    Mariani A; Dowdy SC; Cliby WA; Gostout BS; Jones MB; Wilson TO; Podratz KC
    Gynecol Oncol; 2008 Apr; 109(1):11-8. PubMed ID: 18304622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
    Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
    Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
    Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
    Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A retrospective analysis of the diameter of metastatic lymph nodes in apparently early stage endometrial cancer.
    Boran N; Akdag D; Halici F; Tulunay G; Turan T; Bozok S; Erdogan Z; Kose MF
    Tumori; 2008; 94(5):681-5. PubMed ID: 19112940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival Rates between Early Stage Endometrial Carcinoma With or Without Para-Aortic Lymph Node Resection.
    Thanagumtorn K
    J Med Assoc Thai; 2016 Sep; 99(9):975-81. PubMed ID: 29927197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.